Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Destiny Chemicals is a pharmaceutical chemical manufacturing company headquartered in Ahmedabad, Gujarat, India. Established in 2004, the company specializes in the production of high-purity Active Pharmaceutical Ingredient (API) intermediates and fine chemicals for the global healthcare industry. Their primary product portfolio includes key intermediates for the synthesis of Angiotensin II receptor blockers (ARBs), such as Losartan and Irbesartan, which are used to treat hypertension. Destiny Chemicals provides custom synthesis and contract manufacturing services, leveraging its expertise in complex organic reactions to support pharmaceutical R&D and commercial production. The company operates a state-of-the-art manufacturing facility in the Vatva industrial estate, adhering to stringent quality control measures to ensure compliance with international standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Destiny Chemicals.